What You Should Know:
– Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced a collaboration with Google Cloud to develop a cutting-edge foundation…
Continue Reading
What You Should Know:
– Accenture has made a strategic investment, through Accenture Ventures, in 1910 Genetics, a biotechnology company revolutionizing drug discovery with its AI-powered platform. Terms of the investment were not disclosed.
– The…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, has launched ProPhet, a startup using artificial intelligence to locate small molecules for drug discovery.ProPhet was established following AION Labs’…
Continue Reading
Shash Anand, SVP, Product Strategy, SOTI
Data is central to a wide range of exciting innovations in healthcare.
Wearable devices that monitor vital signs in real-time. AI to predict protein folding, which may speed drug discovery…
Continue Reading
Sam Anwar, Chief Technology Officer, eClinical Solutions
McKinsey & Company estimates it takes up to 12 years to introduce a new drug to the market – a lengthy timeline comprised of many factors including technology…
Continue Reading
I had several friends attending the Becker’s Health IT + Digital Health + Revenue Cycle conference last week in Chicago. In sending me some impressions and notes, they all mentioned conversations around the topic…
Continue Reading
What You Should Know:
– Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.
– These powerful…
Continue Reading
Introduction
In recent years, advancements in technology have significantly impacted cancer research and drug discovery. One of the most exciting developments is the collaboration between MedTech startup Imagene AI and Oracle, which leverages artificial intelligence…
Researchers at King’s College London and Imperial College London have developed an AI algorithm that could help aid drug discovery.
The computer-based tool, named Drug Synthesis using Monte Carlo (DrugSynthMC), expands the diversity within drug…
The following is a guest article by Kenji Taylor, MD, MSc, Clinical Consultant, Supervising Physician at Ubie
Artificial intelligence holds immense potential to revolutionize healthcare, offering precision medicine, accelerated drug discovery, and improved patient outcomes….
